Western blot analysis showed that DNMT3A also regulated the activation of AKT in HCC, which further confirmed and optimized the modulatory axis in HCC as HCP5/miR-29b-3p/DNMT3A/AKT. This evidence concerns the gene HCP5 and hepatocellular carcinoma.